MGTX 8-K 2026-11-12
MeiraGTx Holdings plc (MGTX) 8-K dated 2026-11-12 — accession 0001104659-26-125910.
MeiraGTx Holdings plc (MGTX) is a biotechnology company listed on US.
MGTX: MeiraGTx Reports Third Quarter 2026 Financial and Operational Results
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported MGTX revenue for 2025-12-31 was $81.4M. Net income was -$114.2M. Revenue was up 144.6% from 2024-12-31 to 2025-12-31. MGTX currently screens at market cap $532.8M.
Not investment advice. The MGTX SEC hub lists recent forms. The stock page is the research view.
Why it matters
- Other programs to highlight in the coming quarters, which we have spent years optimizing, are our dry AMD and Geographic Atrophy programs where we are advanc…